Low serum vitamin D level associated with incident advanced liver disease in the general population - a prospective study.


Journal

Scandinavian journal of gastroenterology
ISSN: 1502-7708
Titre abrégé: Scand J Gastroenterol
Pays: England
ID NLM: 0060105

Informations de publication

Date de publication:
Mar 2021
Historique:
pubmed: 23 1 2021
medline: 19 8 2021
entrez: 22 1 2021
Statut: ppublish

Résumé

Vitamin D deficiency is a common finding in chronic liver disease. It has also been linked to the pathogenesis of non-alcoholic fatty liver disease, hepatic fibrogenesis, decompensation and hepatocellular carcinoma. We analyzed whether serum vitamin D is associated with incident advanced liver disease in the general population. Serum 25-hydroxyvitamin D was measured in 13807 individuals participating in the Finnish population-based health examination surveys FINRISK 1997 and Health 2000. Data were linked with incident advanced liver disease (hospitalization, cancer or death related to liver disease). During a follow-up of 201444 person-years 148 severe liver events occurred. Analyses were performed using multivariable Cox regression analyses. Vitamin D level associated with incident advanced liver disease with the hazard ratio of 0.972 (95% confidence interval 0.943-0.976, Low vitamin D level is linked to incident advanced liver disease at population level.

Sections du résumé

BACKGROUND BACKGROUND
Vitamin D deficiency is a common finding in chronic liver disease. It has also been linked to the pathogenesis of non-alcoholic fatty liver disease, hepatic fibrogenesis, decompensation and hepatocellular carcinoma.
AIMS OBJECTIVE
We analyzed whether serum vitamin D is associated with incident advanced liver disease in the general population.
METHODS METHODS
Serum 25-hydroxyvitamin D was measured in 13807 individuals participating in the Finnish population-based health examination surveys FINRISK 1997 and Health 2000. Data were linked with incident advanced liver disease (hospitalization, cancer or death related to liver disease). During a follow-up of 201444 person-years 148 severe liver events occurred. Analyses were performed using multivariable Cox regression analyses.
RESULTS RESULTS
Vitamin D level associated with incident advanced liver disease with the hazard ratio of 0.972 (95% confidence interval 0.943-0.976,
CONCLUSION CONCLUSIONS
Low vitamin D level is linked to incident advanced liver disease at population level.

Identifiants

pubmed: 33478287
doi: 10.1080/00365521.2021.1873412
doi:

Substances chimiques

Vitamin D 1406-16-2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

299-303

Auteurs

Ville Männistö (V)

Departments of Medicine, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland.
Department of Experimental Vascular Medicine, Amsterdam UMC, Location AMC at University of Amsterdam, Amsterdam, The Netherlands.

Tuija Jääskeläinen (T)

Finnish Institute for Health and Welfare, Helsinki, Finland.

Martti Färkkilä (M)

Department of Gastroenterology, Helsinki University Hospital, Helsinki University, Helsinki, Finland.

Antti Jula (A)

Finnish Institute for Health and Welfare, Helsinki, Finland.

Satu Männistö (S)

Finnish Institute for Health and Welfare, Helsinki, Finland.

Annamari Lundqvist (A)

Finnish Institute for Health and Welfare, Helsinki, Finland.

Tanja Zeller (T)

Clinic of Cardiology, University Heart and Vascular Center Hamburg, Hamburg, Germany.
Partner site Hamburg, Lübeck, Kiel, German Center for Cardiovascular Research (DZHK), Hamburg, Germany.

Stefan Blankenberg (S)

Clinic of Cardiology, University Heart and Vascular Center Hamburg, Hamburg, Germany.
Partner site Hamburg, Lübeck, Kiel, German Center for Cardiovascular Research (DZHK), Hamburg, Germany.

Veikko Salomaa (V)

Finnish Institute for Health and Welfare, Helsinki, Finland.

Markus Perola (M)

Finnish Institute for Health and Welfare, Helsinki, Finland.

Fredrik Åberg (F)

Transplantation and Liver Surgery Clinic, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
The Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH